Dyslipidemia and Associated Factors Among a High‐Risk Population for Stroke: A Cross‐Sectional Study
Authors:
- Scovia Nalugo MbalindaSMScovia Nalugo Mbalinda
- Josephine Nambi NajjumaJNJosephine Nambi Najjuma
- Martin KaddumukasaMKMartin Kaddumukasa
- Jane NakibuukaJNJane Nakibuuka
- Doreen BirungiDBDoreen Birungi
- Carla ConroyCCCarla Conroy
- Joy YalaJYJoy Yala
- Levicatus MugenyiLMLevicatus Mugenyi
- Christopher J. BurantCBChristopher J. Burant
- Shirley MooreSMShirley Moore
- Elly T. KatabiraEKElly T. Katabira
- Martha SajatovicMSMartha Sajatovic
Open Access
- 1 January 2026
- journal article
- Published by Wiley in Stroke Research and Treatment
- Vol. 2026 (1)
Abstract
Aims: Dyslipidemia is a major modifiable risk factor for stroke; however, it is poorly understood among patients at risk of stroke in Uganda. This study is aimed at determining the prevalence of dyslipidemia and identifying associated factors among a Ugandan sample at risk for stroke. Methods: This was a hospital based cross‐sectional study conducted across three Ugandan sites. The serum lipid levels were determined following the National Cholesterol Education Program guidelines. Data were analyzed with STATA employing univariable and multivariable logistic regression. Statistical significance was set at p < 0.05. Results: We enrolled 247 study participants with a mean age (SD) of 55.4 (12.0) years. Majority of the participants were female, n = 168 (68%). About 81% ( N = 199) had elevated serum lipid levels. Sixty‐one (24.7%) had elevated levels of total serum cholesterol, whereas half of female participants had abnormally low levels of HDL cholesterol. About a third ( N = 82 and 84, respectively) had elevated serum LDL and triglycerides. Nearly 40% ( N = 98) were obese and 23.5% had a sedentary lifestyle ( N = = 58). Only 20.2% ( N = 50) were receiving lipid lowering drugs. Prior family stroke history and personal history of stroke had lower odds of 58% (AOR = 0.42, 95% CI: 0.20–0.88, p = 0.022); and 64% (AOR = 0.36, 95% CI: 0.17–0.76, p = 0.008), respectively, of having dyslipidemia. Conclusions: Approximately four in five Ugandans at risk of stroke have dyslipidemia. The majority also have low HDL‐c levels. Implementation of systematic screening and provision of statin therapy among those at high risk for stroke is urgently needed to reduce stroke burden in Uganda. Trial Registration: ClinicalTrials.gov identifier: NCT04685408Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R01NS118544)
This publication has 33 references indexed in Scilit:
- Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general populationAnnals of Neurology, 2019
- Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia ManagementJACC, 2018
- Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysisThe Lancet, 2016
- HDL cholesterol and stroke risk: The Multi-Ethnic Study of AtherosclerosisAtherosclerosis, 2015
- Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010The Lancet, 2014
- Lipid profile in Egyptian patients with coronary artery diseaseThe Egyptian Heart Journal, 2012
- Dyslipidemia Among Newly Diagnosed Hypertensives: Pattern and Clinical CorrelatesJournal of the National Medical Association, 2010
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJAMA, 2009
- Tackling the global burden of stroke: the need for large-scale international studiesThe Lancet Neurology, 2009
- Rural and urban differences in blood pressure and hypertension in Ghana, West AfricaPublic Health, 2006